🇺🇸 FDA

Intelligence Platform

Patents

Browse 33 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9018251

Method for treating brain cancer or reducing temozolomide-resistance of brain cancer cells

China Medical University · Granted Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8716315

Analogs of thalidomide as potential angiogenesis inhibitors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7973057

Thalidomide analogs

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7527952

Crystals of inosine monophosphate dehydrogenase/oxidized inosine monophosphate thiomidate

Vertex Pharmaceuticals Incorporated · Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7442806

Processes for preparing darifenacin hydrobromide

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7320991

Analogs of thalidomide as potential angiogenesis inhibitors

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Jan 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6806373

Process for preparing leflunomide form I

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 19 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6723855

Method for synthesizing leflunomide

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6610718

Processes for making- and a new crystalline form of- leflunomide

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired